Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

A randomized double-blind phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG (Alliance) N0923 Study.

Schenk EL, Mandrekar SJ, Dy GK, Aubry MC, Tan AD, Dakhil SR, Sachs BA, Nieva JJ, Bertino E, Lee Hann C, Schild SE, Wadsworth TW, Adjei AA, Molina JR.

J Thorac Oncol. 2019 Oct 9. pii: S1556-0864(19)33411-2. doi: 10.1016/j.jtho.2019.09.083. [Epub ahead of print]

PMID:
31605793
2.

Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.

Duma N, Idossa DW, Durani U, Frank RD, Paludo J, Westin G, Lou Y, Mansfield AS, Adjei AA, Go RS, Ailawadhi S.

Clin Lung Cancer. 2019 Aug 30. pii: S1525-7304(19)30254-2. doi: 10.1016/j.cllc.2019.08.005. [Epub ahead of print]

PMID:
31570228
3.

Outstanding Issues with Umbrella and Basket Studies.

Parikh K, Adjei AA.

J Thorac Oncol. 2019 Oct;14(10):1685-1688. doi: 10.1016/j.jtho.2019.08.011. No abstract available.

PMID:
31558226
4.

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.

Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK.

J Thorac Oncol. 2019 Oct;14(10):1718-1731. doi: 10.1016/j.jtho.2019.08.012. Epub 2019 Aug 27.

PMID:
31470129
5.

Current Diagnosis and Management of Small-Cell Lung Cancer.

Wang S, Zimmermann S, Parikh K, Mansfield AS, Adjei AA.

Mayo Clin Proc. 2019 Aug;94(8):1599-1622. doi: 10.1016/j.mayocp.2019.01.034. Review.

PMID:
31378235
6.

Effect of HIV infection on TB treatment outcomes and time to mortality in two urban hospitals in Ghana-a retrospective cohort study.

Ogyiri L, Lartey M, Ojewale O, Adjei AA, Kwara A, Adanu RM, Torpey K.

Pan Afr Med J. 2019 Apr 26;32:206. doi: 10.11604/pamj.2019.32.206.18673. eCollection 2019.

7.

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.

Tsao MS, Carbone M, Galateau-Salle F, Moreira AL, Nicholson AG, Roden AC, Adjei AA, Aubry MC, Fennell DA, Gomez D, Harpole D, Hesdorffer M, Hirsch FR, Liu G, Malik S, Nowak A, Peikert T, Salgia R, Szlosarek P, Taioli E, Yang H, Tsao A, Mansfield AS.

J Thorac Oncol. 2019 Oct;14(10):1704-1717. doi: 10.1016/j.jtho.2019.06.020. Epub 2019 Jun 28.

PMID:
31260832
8.

5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.

Luo YH, Luo L, Wampfler JA, Wang Y, Liu D, Chen YM, Adjei AA, Midthun DE, Yang P.

Lancet Oncol. 2019 Aug;20(8):1098-1108. doi: 10.1016/S1470-2045(19)30329-8. Epub 2019 Jun 26.

9.

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma.

Xie H, Yin J, Shah MH, Menefee ME, Bible KC, Reidy-Lagunes D, Kane MA, Quinn DI, Gandara DR, Erlichman C, Adjei AA.

Invest New Drugs. 2019 Aug;37(4):755-762. doi: 10.1007/s10637-019-00797-1. Epub 2019 Jun 6.

PMID:
31172443
10.

A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.

Friedberg JS, Culligan MJ, Tsao AS, Rusch V, Sepesi B, Pass HI, Bueno R, Burt B, Sugarbaker DJ, de Perrot M, Adjei AA, Adusumilli PS, Hirsch FR, Malik SM, Harpole DJ Jr.

J Thorac Oncol. 2019 Aug;14(8):1343-1353. doi: 10.1016/j.jtho.2019.04.029. Epub 2019 May 25. Review.

PMID:
31136816
11.

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Gomez DR, Rimner A, Simone CB 2nd, Cho BCJ, de Perrot M, Adjei AA, Bueno R, Gill RR, Harpole DH Jr, Hesdorffer M, Hirsch FR, Jackson AA, Pass HI, Rice DC, Rusch VW, Tsao AS, Yorke E, Rosenzweig K.

J Thorac Oncol. 2019 Jul;14(7):1172-1183. doi: 10.1016/j.jtho.2019.03.030. Epub 2019 May 22. Review.

PMID:
31125736
12.

Lung Cancer Worldwide.

Adjei AA.

J Thorac Oncol. 2019 Jun;14(6):956. doi: 10.1016/j.jtho.2019.04.001. No abstract available.

PMID:
31122558
13.

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma N, Abdel-Ghani A, Yadav S, Hoversten KP, Reed CT, Sitek AN, Enninga EAL, Paludo J, Aguilera JV, Leventakos K, Lou Y, Kottschade LA, Dong H, Mansfield AS, Manochakian R, Adjei AA, Dronca RS.

Oncologist. 2019 Apr 29. pii: theoncologist.2019-0094. doi: 10.1634/theoncologist.2019-0094. [Epub ahead of print]

PMID:
31036771
14.

Progress in the Diagnosis and Treatment of Thoracic Malignancies Continues Unabated.

Adjei AA.

J Thorac Oncol. 2019 May;14(5):757. doi: 10.1016/j.jtho.2019.02.022. No abstract available.

PMID:
31027737
15.

Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt".

Gouveia MH, Bergen AW, Borda V, Nunes K, Leal TP, Ogwang MD, Yeboah ED, Mensah JE, Kinyera T, Otim I, Nabalende H, Legason ID, Mpoloka SW, Mokone GG, Kerchan P, Bhatia K, Reynolds SJ, Birtwum RB, Adjei AA, Tettey Y, Tay E, Hoover R, Pfeiffer RM, Biggar RJ, Goedert JJ, Prokunina-Olsson L, Dean M, Yeager M, Lima-Costa MF, Hsing AW, Tishkoff SA, Chanock SJ, Tarazona-Santos E, Mbulaiteye SM.

PLoS Genet. 2019 Mar 8;15(3):e1008027. doi: 10.1371/journal.pgen.1008027. eCollection 2019 Mar.

16.

Antibody-Drug Conjugates for the Therapy of Thoracic Malignancies.

Xie H, Adjei AA.

J Thorac Oncol. 2019 Mar;14(3):358-376. doi: 10.1016/j.jtho.2018.11.034. Epub 2018 Dec 30. Review.

PMID:
30599202
17.

Diagnostic capacity, and predictive values of rapid diagnostic tests for accurate diagnosis of Plasmodium falciparum in febrile children in Asante-Akim, Ghana.

Quakyi IA, Adjei GO, Sullivan DJ Jr, Laar A, Stephens JK, Owusu R, Winch P, Sakyi KS, Coleman N, Krampa FD, Essuman E, Aubyn VNA, Boateng IA, Borteih BB, Vanotoo L, Tuakli J, Addison E, Bart-Plange C, Sorvor F, Adjei AA.

Malar J. 2018 Dec 14;17(1):468. doi: 10.1186/s12936-018-2613-x.

18.

Usual adult occupation and risk of prostate cancer in West African men: the Ghana Prostate Study.

Adler C, Friesen MC, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Okyne V, Mensah JE, Truelove A, Yang B, Kelly SP, Zhou CK, McCullough LE, Pardo L, Hoover RN, Hsing AW, Cook MB, Koutros S.

Occup Environ Med. 2019 Feb;76(2):71-77. doi: 10.1136/oemed-2018-105391. Epub 2018 Dec 7.

19.

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.

Ma WW, Xie H, Fetterly G, Pitzonka L, Whitworth A, LeVea C, Wilton J, Mantione K, Schihl S, Dy GK, Boland P, Iyer R, Tan W, Brady W, Straubinger RM, Adjei AA.

Am J Clin Oncol. 2019 Feb;42(2):184-189. doi: 10.1097/COC.0000000000000492.

PMID:
30418178
20.

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.

Duma N, Kothadia SM, Azam TU, Yadav S, Paludo J, Vera Aguilera J, Gonzalez Velez M, Halfdanarson TR, Molina JR, Hubbard JM, Go RS, Mansfield AS, Adjei AA.

Oncologist. 2019 Jan;24(1):96-102. doi: 10.1634/theoncologist.2017-0687. Epub 2018 Nov 9.

PMID:
30413668
21.

A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors.

Wang F, Molina J, Satele D, Yin J, Lim VS, Adjei AA.

Invest New Drugs. 2019 Aug;37(4):658-665. doi: 10.1007/s10637-018-0690-x. Epub 2018 Oct 31.

PMID:
30382439
22.

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM.

J Thorac Oncol. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036. Epub 2018 Sep 25.

PMID:
30266660
23.

Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate.

Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, Pugh E, Romm J, Shelford T, Chinegwundoh F, Adusei B, Mante S, Snyper NY, Agalliu I, Lounsbury DW, Rohan T, Orfanos A, Quintana Y, Jacobson JS, Neugut AI, Gelmann E, Lachance J, Dial C, Diallo TA, Jalloh M, Gueye SM, Kane PMS, Diop H, Ndiaye AJ, Sall AS, Toure-Kane NC, Onyemata E, Abimiku A, Adjei AA, Biritwum R, Gyasi R, Kyei M, Mensah JE, Okine J, Okyne V, Rockson I, Tay E, Tettey Y, Yeboah E, Chen WC, Singh E, Cook MB, Duffy CN, Hsing A, Soo CC, Fernandez P, Irusen H, Aisuodionoe-Shadrach O, Jamda AM, Olabode PO, Nwegbu MM, Ajibola OH, Ajamu OJ, Ambuwa YG, Adebiyi AO, Asuzu M, Ogunbiyi O, Popoola O, Shittu O, Amodu O, Odiaka E, Makinde I, Joffe M, Pentz A, Rebbeck TR.

J Glob Oncol. 2018 Sep;4:1-14. doi: 10.1200/JGO.18.00063.

24.

Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.

Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay É, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL.

Ann Am Thorac Soc. 2019 Jan;16(1):22-28. doi: 10.1513/AnnalsATS.201808-564PS. No abstract available. Erratum in: Ann Am Thorac Soc. 2019 Feb;16(2):283.

25.

Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations.

Le-Rademacher J, Dahlberg S, Lee JJ, Adjei AA, Mandrekar SJ.

J Thorac Oncol. 2018 Nov;13(11):1625-1637. doi: 10.1016/j.jtho.2018.08.2019. Epub 2018 Sep 4. Review.

PMID:
30194034
26.

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers.

Lou Y, Dholaria B, Soyano A, Hodge D, Cochuyt J, Manochakian R, Ko SJ, Thomas M, Johnson MM, Patel NM, Miller RC, Adjei AA, Ailawadhi S.

Cancer Med. 2018 Oct;7(10):4932-4942. doi: 10.1002/cam4.1749. Epub 2018 Sep 2.

27.

WITHDRAWN: What is a "High-Impact" Journal?

Adjei AA.

J Thorac Oncol. 2018 Aug 26. pii: S1556-0864(18)30813-X. doi: 10.1016/j.jtho.2018.07.018. [Epub ahead of print]

PMID:
30158066
28.

Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.

Goyal G, Kommalapati A, Bartley AC, Gunderson TM, Adjei AA, Go RS.

Lung Cancer. 2018 Aug;122:214-219. doi: 10.1016/j.lungcan.2018.06.025. Epub 2018 Jun 19.

PMID:
30032834
29.

HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana.

Simpong DL, Asmah RH, Krampah C, Akakpo PK, Adu P, Asante DB, Naporo S, Adjei AA, Gyasi RK.

ScientificWorldJournal. 2018 Mar 14;2018:1564150. doi: 10.1155/2018/1564150. eCollection 2018.

30.

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.

Yan Y, Cao S, Liu X, Harrington SM, Bindeman WE, Adjei AA, Jang JS, Jen J, Li Y, Chanana P, Mansfield AS, Park SS, Markovic SN, Dronca RS, Dong H.

JCI Insight. 2018 Apr 19;3(8). pii: 97828. doi: 10.1172/jci.insight.97828. eCollection 2018 Apr 19.

31.

2017-A Banner Year for Thoracic Oncology.

Adjei AA.

J Thorac Oncol. 2018 Mar;13(3):290. doi: 10.1016/j.jtho.2018.01.014. No abstract available.

32.

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.

Moschos SJ, Sullivan RJ, Hwu WJ, Ramanathan RK, Adjei AA, Fong PC, Shapira-Frommer R, Tawbi HA, Rubino J, Rush TS 3rd, Zhang D, Miselis NR, Samatar AA, Chun P, Rubin EH, Schiller J, Long BJ, Dayananth P, Carr D, Kirschmeier P, Bishop WR, Deng Y, Cooper A, Shipps GW, Moreno BH, Robert L, Ribas A, Flaherty KT.

JCI Insight. 2018 Feb 22;3(4). pii: 92352. doi: 10.1172/jci.insight.92352. eCollection 2018 Feb 22.

33.

Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.

Xie H, Adjei AA.

Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S41-S43. doi: 10.21037/tlcr.2017.10.15. No abstract available.

34.

Targeted community based interventions improved malaria management competencies in rural Ghana.

Quakyi IA, Adjei GO, Sullivan DJ Jr, Stephens JK, Laar A, Ama Aubyn VN, Owusu R, Sakyi KS, Coleman N, Krampa FD, Vanotoo L, Tuakli J, Bortei BB, Essuman E, Sorvor F, Boateng IA, Bart-Plange C, Addison EA, Winch P, Adjei AA.

Glob Health Res Policy. 2017 Oct 2;2:29. doi: 10.1186/s41256-017-0048-5. eCollection 2017.

35.

MANAGEMENT OF PROSTATE CANCER IN ACCRA, GHANA.

Yeboah ED, Hsing AW, Mante S, Mensah JE, Kyei MY, Yarney J, Vanderpuye V, Beecham K, Tettey Y, Biritwum RB, Adjei AA, Gyasi R, Asante K, Ampadu KN, Klufio GO, Gepi-Attee S, Owoo C, Kwami D, Ahiaku, Pandra R, Cook MB.

J West Afr Coll Surg. 2016 Oct-Dec;6(4):31-65.

36.

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.

Wakelee HA, Dahlberg SE, Keller SM, Tester WJ, Gandara DR, Graziano SL, Adjei AA, Leighl NB, Aisner SC, Rothman JM, Patel JD, Sborov MD, McDermott SR, Perez-Soler R, Traynor AM, Butts C, Evans T, Shafqat A, Chapman AE, Kasbari SS, Horn L, Ramalingam SS, Schiller JH; ECOG-ACRIN.

Lancet Oncol. 2017 Dec;18(12):1610-1623. doi: 10.1016/S1470-2045(17)30691-5. Epub 2017 Nov 9.

37.

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, John EM, Park JY, Xu J, Stevens VL, Berndt SI, Huff CD, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Sellers TA, Yamoah K, Murphy AB, Crawford DC, Gapstur SM, Bush WS, Aldrich MC, Cussenot O, Petrovics G, Cullen J, Neslund-Dudas C, Stern MC, Jarai ZK, Govindasami K, Chokkalingam AP, Hsing AW, Goodman PJ, Hoffmann T, Drake BF, Hu JJ, Clark PE, Van Den Eeden SK, Blanchet P, Fowke JH, Casey G, Hennis AJM, Han Y, Lubwama A, Thompson IM Jr, Leach R, Easton DF, Schumacher F, Van den Berg DJ, Gundell SM, Stram A, Wan P, Xia L, Pooler LC, Mohler JL, Fontham ETH, Smith GJ, Taylor JA, Srivastava S, Eeles RA, Carpten J, Kibel AS, Multigner L, Parent ME, Menegaux F, Cancel-Tassin G, Klein EA, Brureau L, Stram DO, Watya S, Chanock SJ, Witte JS, Blot WJ, Henderson BE, Haiman CA; PRACTICAL/ELLIPSE Consortium.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx084.

38.

Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years.

Duma N, Vera Aguilera J, Paludo J, Haddox CL, Gonzalez Velez M, Wang Y, Leventakos K, Hubbard JM, Mansfield AS, Go RS, Adjei AA.

J Oncol Pract. 2018 Jan;14(1):e1-e10. doi: 10.1200/JOP.2017.025288. Epub 2017 Nov 3. Review.

PMID:
29099678
39.

Lung Cancer Awareness Month-A Lot of Progress, But More Work Needs to Be Done.

Henningfield MF, Adjei AA.

J Thorac Oncol. 2017 Nov;12(11):1603-1605. doi: 10.1016/j.jtho.2017.09.091. No abstract available. Erratum in: J Thorac Oncol. 2018 Apr;13(4):587.

40.

A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancer.

Soria JC, Adjei AA, Bahleda R, Besse B, Ferte C, Planchard D, Zhou J, Ware J, Morrissey K, Shankar G, Lin W, Schutzman JL, Dy GK, Groen HJM.

Eur J Cancer. 2017 Nov;86:186-196. doi: 10.1016/j.ejca.2017.08.027. Epub 2017 Oct 6.

PMID:
28992562
41.

Unrecognized human immunodeficiency virus infection and risk factors among elderly medical patients at the Korle Bu teaching hospital, Accra, Ghana.

Adjei AA, Agyemang S, Krampa FD, Abdul-Rahman M, Ofei F, Lartey M, Adiku TK, Gyasi RK, Tettey Y.

Trop Dis Travel Med Vaccines. 2016 Sep 2;2:18. doi: 10.1186/s40794-016-0034-9. eCollection 2016.

42.

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

Goetz MP, Suman VJ, Reid JM, Northfelt DW, Mahr MA, Ralya AT, Kuffel M, Buhrow SA, Safgren SL, McGovern RM, Black J, Dockter T, Haddad T, Erlichman C, Adjei AA, Visscher D, Chalmers ZR, Frampton G, Kipp BR, Liu MC, Hawse JR, Doroshow JH, Collins JM, Streicher H, Ames MM, Ingle JN.

J Clin Oncol. 2017 Oct 20;35(30):3391-3400. doi: 10.1200/JCO.2017.73.3246. Epub 2017 Aug 30.

43.

The Journal of Thoracic Oncology Achieves a New Benchmark.

Adjei AA.

J Thorac Oncol. 2017 Sep;12(9):1334. doi: 10.1016/j.jtho.2017.07.007. No abstract available.

44.

Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events.

Anwar S, Tan W, Hong CC, Admane S, Dozier A, Siedlecki F, Whitworth A, DiRaddo AM, DePaolo D, Jacob SM, Ma WW, Miller A, Adjei AA, Dy GK.

Cancers (Basel). 2017 Jun 26;9(7). pii: E73. doi: 10.3390/cancers9070073.

45.

TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences.

Zhou CK, Young D, Yeboah ED, Coburn SB, Tettey Y, Biritwum RB, Adjei AA, Tay E, Niwa S, Truelove A, Welsh J, Mensah JE, Hoover RN, Sesterhenn IA, Hsing AW, Srivastava S, Cook MB.

Am J Epidemiol. 2017 Dec 15;186(12):1352-1361. doi: 10.1093/aje/kwx235. Review.

46.

Management of Multifocal Lung Cancer: Results of a Survey.

Leventakos K, Peikert T, Midthun DE, Molina JR, Blackmon S, Nichols FC, Garces YI, Hallemeier CL, Murphy SJ, Vasmatzis G, Kratz SL, Holland WP, Thomas CF, Mullon JJ, Shen KR, Cassivi SD, Marks RS, Aubry MC, Adjei AA, Yang P, Allen MS, Edell ES, Wigle D, Mansfield AS.

J Thorac Oncol. 2017 Sep;12(9):1398-1402. doi: 10.1016/j.jtho.2017.05.013. Epub 2017 Jun 3.

47.

Detection of Human Papillomavirus Genotypes and Epstein-Barr Virus in Nasopharyngeal Carcinomas at the Korle-Bu Teaching Hospital, Ghana.

Asante DB, Asmah RH, Adjei AA, Kyei F, Simpong DL, Brown CA, Gyasi RK.

ScientificWorldJournal. 2017;2017:2721367. doi: 10.1155/2017/2721367. Epub 2017 Mar 21.

48.

Predicting Clinical Outcomes Using Proteomics in Non-Small Cell Lung Cancer-The Past, Present, and Future.

Soo RA, Adjei AA.

J Thorac Oncol. 2017 Apr;12(4):602-606. doi: 10.1016/j.jtho.2017.01.025. No abstract available.

49.

Design considerations for identifying breast cancer risk factors in a population-based study in Africa.

Brinton LA, Awuah B, Nat Clegg-Lamptey J, Wiafe-Addai B, Ansong D, Nyarko KM, Wiafe S, Yarney J, Biritwum R, Brotzman M, Adjei AA, Adjei E, Aitpillah F, Edusei L, Dedey F, Nyante SJ, Oppong J, Osei-Bonsu E, Titiloye N, Vanderpuye V, Brew Abaidoo E, Arhin B, Boakye I, Frempong M, Ohene Oti N, Okyne V, Figueroa JD.

Int J Cancer. 2017 Jun 15;140(12):2667-2677. doi: 10.1002/ijc.30688. Epub 2017 Mar 28.

50.

Hepatitis B virus genotypes among chronic hepatitis B patients reporting at Korle-Bu teaching hospital, Accra, Ghana.

Dongdem AZ, Dzodzomenyo M, Asmah RH, Nyarko KM, Nortey P, Agyei A, Adjei DN, Kenu E, Adjei AA.

Pan Afr Med J. 2016 Oct 1;25(Suppl 1):5. doi: 10.11604/pamj.supp.2016.25.1.6170. eCollection 2016.

Supplemental Content

Loading ...
Support Center